BlueCrest Capital Management’s Precigen PGEN Stock Holding History

BlueCrest Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,880	Closed	-$68K	–	881
2019 Q1	$68K	Buy	+12,880	New	+$89.3K	﹤0.01%	1115
2017 Q3	–	Sell	-18,180	Closed	-$438K	–	1039
2017 Q2	$438K	Buy	+18,180	New	+$399K	0.02%	612
2016 Q2	–	Sell	-10,118	Closed	-$340K	–	1003
2016 Q1	$340K	Buy	+10,118	New	+$319K	0.02%	568
2015 Q3	–	Sell	-25,480	Closed	-$1.23M	–	1014
2015 Q2	$1.23M	Buy	+25,480	New	+$1.07M	0.04%	451

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlueCrest Capital Management's PGEN Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Precigen (PGEN) in Q2 2019, closing a stake of 12,880 shares — an estimated $68K sold.

BlueCrest Capital Management first reported a position in PGEN in Q2 2015 and held it in 4 quarters. The position peaked at $1.23M in Q2 2015. 162 funds tracked by Wall St. Rank hold PGEN as of Q2 2019.

BlueCrest Capital Management reported no remaining Precigen position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 12,880 Precigen shares in Q2 2019, an estimated $68K.
BlueCrest Capital Management first reported a position in Precigen in Q2 2015 and held it in 4 quarters.
BlueCrest Capital Management's Precigen position peaked at $1.23M in Q2 2015.
162 funds tracked by Wall St. Rank held Precigen as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.